John W.  Kapples net worth and biography

John Kapples Biography and Net Worth

Senior Vice President and General Counsel of Insulet

Mr. Kapples has served as our Senior Vice President and General Counsel since March 2019 and Secretary from March 2019 to December 2021. From 2015 to 2019, he served as Vice President, Secretary and General Counsel at GCP Applied Technologies, Inc. Prior, Mr. Kapples served as Vice President and Corporate Secretary of Covidien plc from 2006 to 2015, which was acquired by Medtronic plc. in 2015. At Covidien, he was responsible for building the Company’s legal structure and compliance framework, as well as advising on strategic transactions and global partnerships. From 1994 to 2006, Mr. Kapples served in various roles of increasing responsibility at Raytheon Company, including Assistant General Counsel and Secretary, and from 1985 to 1993 he was a Corporate Associate at Sullivan & Worcester LLP. Mr. Kapples earned both his Bachelor of Arts in English and his Juris Doctor from Georgetown University. He is a member of the Massachusetts Bar Association and the Society of Corporate Secretaries & Governance Professionals.

What is John W. Kapples' net worth?

The estimated net worth of John W. Kapples is at least $7.32 million as of May 14th, 2025. Mr. Kapples owns 23,180 shares of Insulet stock worth more than $7,323,026 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Kapples may own. Additionally, Mr. Kapples receives a salary of $1,020,000.00 as Senior Vice President and General Counsel at Insulet. Learn More about John W. Kapples' net worth.

How old is John W. Kapples?

Mr. Kapples is currently 64 years old. There are 9 older executives and no younger executives at Insulet. Learn More on John W. Kapples' age.

What is John W. Kapples' salary?

As the Senior Vice President and General Counsel of Insulet Corporation, Mr. Kapples earns $1,020,000.00 per year. There are 2 executives that earn more than Mr. Kapples. The highest earning executive at Insulet is Dr. James R. Hollingshead Ph.D., President, CEO & Director, who commands a salary of $2,880,000.00 per year. Learn More on John W. Kapples' salary.

How do I contact John W. Kapples?

The corporate mailing address for Mr. Kapples and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on John W. Kapples' contact information.

Has John W. Kapples been buying or selling shares of Insulet?

John W. Kapples has not been actively trading shares of Insulet over the course of the past ninety days. Most recently, John W. Kapples sold 5,278 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were sold at an average price of $318.47, for a transaction totalling $1,680,884.66. Following the completion of the sale, the senior vice president now directly owns 23,180 shares of the company's stock, valued at $7,382,134.60. Learn More on John W. Kapples' trading history.

Who are Insulet's active insiders?

Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Laetitia Cousin (SVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), Wayne Frederick (Director), James Hollingshead (CEO), John Kapples (Senior Vice President and General Counsel), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.

Are insiders buying or selling shares of Insulet?

In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 21,896 shares worth more than $6,421,999.16. The most recent insider tranaction occured on September, 8th when SVP Prem Singh sold 687 shares worth more than $238,725.63. Insiders at Insulet own 0.4% of the company. Learn More about insider trades at Insulet.

Information on this page was last updated on 9/8/2025.

John W. Kapples Insider Trading History at Insulet

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/14/2025Sell5,278$318.47$1,680,884.6623,180View SEC Filing Icon  
See Full Table

John W. Kapples Buying and Selling Activity at Insulet

This chart shows John W Kapples's buying and selling at Insulet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Insulet Company Overview

Insulet logo
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Read More

Today's Range

Now: $315.92
Low: $305.05
High: $317.34

50 Day Range

MA: $320.58
Low: $305.98
High: $346.36

2 Week Range

Now: $315.92
Low: $230.05
High: $354.88

Volume

757,024 shs

Average Volume

779,667 shs

Market Capitalization

$22.22 billion

P/E Ratio

91.57

Dividend Yield

N/A

Beta

1.37